Novartis International AG /
Novartis receives EU approval for Ilaris® in active Systemic Juvenile Idiopathic
Arthritis, a serious form of childhood arthritis
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
* Ilaris ...
↧